International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE

Clinical and Vaccine Immunology

Volumn 22, Issue 8, 2015, Pages 957-964

  Laurie, Karen L ^a   Engelhardt, Othmar G ^b   Wood, John ^b   Heath, Alan ^b   Katz, Jacqueline M ^c   Peiris, Malik ^d   Hoschler, Katja ^e   Hungnes, Olav ^f   Zhang, Wenqing ^g   Van Kerkhove, Maria D ^h   Katz, Jaccqueline ^c   Lu, Xiuhua ^c   Levine, Min ^c   Veguilla, Vic ^c   Liu, Feng ^c   Bai, Yaohui ^c   Puthavathana, Pilaipan ⁱ   Lerdsamran, Hatairat ⁱ   Pooruk, Phisanu ⁱ   Nateerom, Knnika ⁱ   Castrucci, Maria Rita ^j   Donatelli, Isabella ^j   Facchini, Marzia ^j   Kishida, Noriko ^k   Tashiro, Masato ^k   Odagiri, Takato ^k   Pawar, Shailesh D ^l   Kode, Sadhana S ^l   Hawksworth, Anthony ^m   Ortiguerra, Ryan ^m   Brice, Gary ^m   Martin, Nicholas ⁿ   Kochel, Tad ⁿ   Sanchez, Jose ⁿ   Cooper, Michael ⁿ   Cummings, James ⁿ   Wagner, Ralf ^o   Goepfert, Constanze ^o   Alex, Nina ^o   Hammann, Joanna ^o   Neumann, Britta ^o   Perera, Mahendra ^d   Montomoli, Emanuele ^p   Lapini, Guilia ^p   Sbragi, Sara ^p   Bai, Tian ^q   Yu, Zaijiang ^q   Zhou, Jianfang ^q   Carolan, Louise ^r   Laurie, Karen ^r   more..

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h INSTITUT PASTEUR   (France)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^k NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^l NATIONAL INSTITUTE OF VIROLOGY   (India)

^m US Naval Health Research Center   (United States)

ⁿ NAVAL MEDICAL RESEARCH CENTER   (United States)

^o PAUL EHRLICH INSTITUT   (Germany)

^p UNIVERSITY OF SIENA   (Italy)

^q State Key Laboratory for Molecular Virology and Genetic Engineering   (China)

^r VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ACCURACY; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOASSAY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MICRONEUTRALIZATION ASSAY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; VIRUS HEMAGGLUTINATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; BLOOD; CLINICAL TRIAL; FERRET; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N1); INFLUENZA, HUMAN; INTERNATIONAL COOPERATION; MULTICENTER STUDY; ORTHOMYXOVIRIDAE INFECTIONS; PROCEDURES; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARDS; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; INTERNATIONAL COOPERATION; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84939480223     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00278-15     Document Type: Article

References (20)

1. Chen MI, Barr IG, Koh GCH, Lee VJ, Lee CPS, Shaw R, Lin C, Yap J, Cook AR, Tan BH, Loh JP, Barkham T, Chow VTK, Lin RTP, Leo YS. 2010. Serological response in RT-PCR confirmed H1N1-2009 influenza A by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS One 5:e12474. http://dx.doi.org/10.1371/journal.pone.0012474.
2. Dong L, Bo H, Bai T, Gao R, Dong J, Zhang Y, Guo J, Zou S, Zhou J, Zhu Y, Xin L, Li X, Xu C, Wang D, Shu Y. 2014. A combination of serological assays to detect human antibodies to the avian influenza A H7N9 virus. PLoS One 9:e95612. http://dx.doi.org/10.1371/journal.pone .0095612.
3. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. 2010. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375:1100-1108. http://dx.doi.org/10.1016/S0140-6736(09)62126-7.
4. Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, Aranio D, Branch A, Dong L, Holiday C, Liu F, Steward-Clark E, Sun H, Tsang B, Wang D, Whaley M, Bai Y, Cronin L, Browning P, Dababneh H, Noland H, Thomas L, Foster L, Quinn CP, Soroka SD, Katz JM. 2011. Sensitivity and specificity of serologic assays for the detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 49:2210-2215. http://dx.doi.org/10.1128/JCM.00229-11.
5. Laurie KL, Huston P, Riley S, Katz JM, Willison DJ, Tam JS, Mounts AW, Hoschler K, Miller E, Vandemaele K, Broberg E, Van Kerkhove MD, Nicoll A. 30 April 2012. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respir Viruses http://dx.doi.org/10.1111/j.1750-2659.2012.0370a.x.
6. Van Kerkhove MD, Broberg E, Engelhardt OG, Wood J, Nicoll A, The CONSISE Steering Committee. 26 December 2012. The Consortium for the Standardization of Influenza Seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy. Influenza Other Respir Viruses http://dx.doi.org/10.1111/irv.12068.
7. Laurie KL, Engelhardt OG, Wood J, Van Kerkhove M. 2014. Global seroepidemiology: value and limitations, p 51-66. In Oxford J (ed), Clinical insights: influenza surveillance. Future Medicine Ltd http://dx.doi.org/10.2217/ebo.13.504.
8. World Health Organization Global Influenza Surveillance Network (GISN). 2011. Manual for the laboratory diagnosis and virological surveillance of influenza. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/gisrs-laboratory/manual-diagnosis-surveillance-influenza/en/.
9. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37:937-943.
10. World Health Organization Global Influenza Programme (GIP). 2002. WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS/2002.5 Rev.1. World Health Organization, Geneva, Switzerland.
11. Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R. 2004. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Virus Res 103:163-171. http://dx.doi.org/10.1016/j.virusres.2004.02.029.
12. Stephenson I, Das RG, Wood JM, Katz JM. 2007. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 25:4056-4063. http://dx.doi.org/10.1016/j.vaccine.2007.02.039.
13. Stephenson I, Heath A, Major D, Newman RW, Hoschler K, Junzi W, Katz JM, Weir JP, Zambon MC, Wood JM. 2009. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 15:1250-1259. http://dx.doi.org/10.3201/eid1508.081754.
14. Wood JM, Gaines-Das RE, Taylor J, Chakraverty P. 1994. Comparison of influenza serological techniques by international collaborative study. Vaccine 12:167-174. http://dx.doi.org/10.1016/0264-410X(94)90056-6.
15. Wood JM, Major D, Heath A, Newman RW, Höschler K, Stephenson I, Clark T, Katz JM, Zambon MC. 2012. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 30:210-217. http://dx.doi.org/10.1016/j.vaccine.2011.11.019.
16. Tannock GA, Paul JA, Herd R, Barry RD, Reid AL, Hensley MJ, Gillett RS, Gillett SM, Lawrance P, Henry RL, Saunders NA. 1989. Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection. J Clin Microbiol 27:524-528.
17. CONSISE Laboratory Working Group. 15 January 2014. Consensus protocols for laboratory assay of antibody to influenza A(H1N1)pdm09. https://consise .tghn.org/articles/consensus-protocols-laboratory-assay-antibody-influenza-h1n1pdm09/.
18. Frace AM, Klimov AI, Katz JM. January 2001. Preparation and use of recombinant influenza A virus M2 construct vaccine. US patent 6,169,175.
19. Crawford PC, Gibbs PJ, Dubovi EJ, Donis RO, Katz JM, Klimov AI, Lakshmanan NP, Lum MA, Goovaerts DGE, Mellencamp MW, Cox NJ, Castleman WL. June 2011. Materials and methods for respiratory disease control in canines. US patent 7,959,929.
20. Sambhara S, Katz JM, Hoelscher M, Mittal SK, Bangari DS. April 2012. An effective vaccine against pandemic strains of influenza viruses. US patent 8,163,545.